quinta-feira, 26 de novembro de 2015

Constituents and Pharmacological Activities of Myrcia (Myrtaceae): A Review of an Aromatic and Medicinal Group of Plants

Cascaes, M.M.; Guilhon, G.M.S.P.; Andrade, E.H.A.; Zoghbi, M.G.B.; Santos, L.S. Constituents and Pharmacological Activities of Myrcia (Myrtaceae): A Review of an Aromatic and Medicinal Group of Plants. Int. J. Mol. Sci. 2015, 16, 23881-23904.
Review

1 Programa de Pós-graduação em Química, Universidade Federal do Pará, Belém 66075-110, PA, Brazil2 Museu Paraense Emílio Goeldi, Belém 66040-170, PA, Brazil
* Author to whom correspondence should be addressed.
Received: 13 August 2015 / Revised: 24 September 2015 / Accepted: 25 September 2015 / Published: 9 October 2015
(This article belongs to the Special Issue Molecular Research in Plant Secondary Metabolism 2015)
View Full-Text | Download PDF [769 KB, uploaded 9 October 2015] | Browse Figures 

Abstract

Myrcia is one of the largest genera of the economically important family Myrtaceae. Some of the species are used in folk medicine, such as a group known as “pedra-hume-caá” or “pedra-ume-caá” or “insulina vegetal” (insulin plant) that it is used for the treatment of diabetes. The species are an important source of essential oils, and most of the chemical studies on Myrcia describe the chemical composition of the essential oils, in which mono- and sesquiterpenes are predominant. The non-volatile compounds isolated from Myrcia are usually flavonoids, tannins, acetophenone derivatives and triterpenes. Anti-inflammatory, antinociceptive, antioxidant, antimicrobial activities have been described to Myrcia essential oils, while hypoglycemic, anti-hemorrhagic and antioxidant activities were attributed to the extracts. Flavonoid glucosides and acetophenone derivatives showed aldose reductase and α-glucosidase inhibition, and could explain the traditional use of Myrcia species to treat diabetes. Antimicrobial and anti-inflammatory are some of the activities observed for other isolated compounds from Myrcia.


See more at:

Nenhum comentário:

Postar um comentário